Table 5: Dominance analysis.

Treatments Returns and Costs in USD
Gross Return Total Varying Cost Net Return Net Income Over Control Marginal Rate of Return (%)
N0 S0 K0 4609.71 - 460.97 - -
N0 S15K0 6027.75 410.27 5617.49 5156.52 1256.87
N0 S0 K45 4930.62 454.68 4475.93 4014.96 -2570.17
N69S0 K0 7892.45 459.47 7432.98 6972.01 61721.14
N92S0 K0 10784.91 474.89 10310.02 9849.05 18666.53
N0 S15K45 6461.41 482.54 5978.87 5517.89 -56587.25
N69S15K0 9453.60 487.33 8966.27 8505.30 62354.74
N92S15K0 12315.70 502.74 11812.95 11351.98 18469.58
N0 S0 K67 5390.29 526.95 4863.33 4402.36 -28703.67
N69S0 K45 8196.01 531.75 7664.26 7203.29 58462.64
N92S0 K45 11058.11 547.16 10510.95 10049.98 18469.58
N0 S15K67 6838.68 554.81 6283.87 5822.90 -55227.48
N69S15K45 9770.16 559.60 9210.56 8749.59 61087.55
N69S15K45 12619.25 575.02 12044.24 11583.27 18385.17
N45S0 K67 8642.67 604.02 8038.65 7577.68 -13811.12
N92S0 K67 11491.76 619.43 10872.33 10411.36 18385.17
N69S15K67 10234.17 631.88 9602.29 9141.32 -10205.23
N92S15K67 13083.26 647.29 12435.97 11975.00 18385.17

Values in bold indicate dominated treatment